Adrenaline and Nebulized Salbutamol in Acute Asthma

Total Page:16

File Type:pdf, Size:1020Kb

Adrenaline and Nebulized Salbutamol in Acute Asthma Arch Dis Child: first published as 10.1136/adc.59.7.666 on 1 July 1984. Downloaded from 666 Oates titioner may have to overcome his own disbelief and bruising in 400 normal children with that found in 84 reluctance to become involved and is then faced abused children and showed that the pattern of with trying to establish the diagnosis in the face of bruising was different in the two groups, with parents who may be uncooperative or untruthful. injuries to the head, face, and lumbar region being Other factors adding to the difficulty in reaching a much more common in the abused group. diagnosis may include a concern about the confiden- Although this information is useful, the ultimate tiality of the doctor-patient relationship on the one diagnosis depends on a combination of history, hand and some anxiety about potential professional physical findings, evaluation of the parents, and the and even public castigation should a case be missed. practitioner's own experience and acumen. Un- There may also be guidelines or statutory require- doubtedly, many instances of child abuse still go ments which outline the steps necessary for the unrecognised but these three cases emphasise the diagnosis and subsequent registration of child abuse important role and responsibility of the paediatri- cases. In New South Wales, the 1977 amendment to cian not only in being aware of the clinical features the Child Welfare Act requires doctors to notify the of child abuse, but also in conducting a careful Department of Youth and Community Services medical, in addition to a social, investigation of each whenever they have reasonable grounds to suspect case. child abuse. Any member of the public may also make a notification. On receipt of a notification References social workers from the department investigate the Anonymous. Child abuse: the swing of the pendulum lEdi- circumstances of the injury, seeking expert medical torial]. Br Med J 1981;283:170. advice at times, before deciding whether to register 2 Tulloch AL. Gangrene of the digits of an infant caused by nylon the case. Apart from the mandatory notification for mittens. Med J Aust 1973-2:501-2. doctors, the United Kingdom guidelines for the 3 Schmitt BD. The child with non-accidental trauma. In: Kempe CH, Helfer RE, eds. The battered child. 3rd ed. registration of child abuse are similar in that they Chicago: University of Chicago Press, 1980:128-46. emphasise the requirement for medical and social 4 Steele BF, Pollock CD. A psychiatric study of parents who investigation before the diagnosis may be made. abuse infants and small children. In: Helfer RE, Kempe CH, texts the eds. The battered child. 2nd ed. Chicago: University of Chicago As well as the standard describing Press, 1974:89-133. typical injuries of abused children3 and the charac- 5 Helfer RE, Slovis TL, Black M. Injuries resulting when small teristics of their parents,4 some work has been done children fall out of bed. Pediatrics 1977;60:533-5. in finding ways of differentiating accidental from 6 Roberton DM, Barbor P, Hull D. Unusual injury? Recent 5 injury in normal children and children with suspected non- non-accidental injury. Helfer et al studied 246 http://adc.bmj.com/ children aged under 5 years who fell out of bed and accidental injury. Br Med J 1982;285:1399-401. found that none had sustained serious injury, the Correspondence to Dr R K Oates, Royal Alexandra Hospital for implication being that severe injuries which are said Children, Camperdown NSW 2050, Australia. to be from falling out of bed should be regarded with suspicion. Roberton et al,6 compared the pattern of Received 5 March 1984 on September 27, 2021 by guest. Protected copyright. Adrenaline and nebulized salbutamol in acute asthma M TURPEINEN, J KUOKKANEN, AND A BACKMAN Allergy Hospital and Department of Pediatrics, University Central Hospital of Helsinki, Finland Although adrenaline is still frequently used for the SUMMARY The effects of injected adrenaline and treatment of acute asthma in children, the short nebulized salbutamol on acute asthma were com- duration of its bronchodilatory effect and the pain of pared in 46 children. The results showed that injection are definite disadvantages. Its use is salbutamol had a significantly better bronchodila- further restricted by the increased heart rate caused tory effect than adrenaline. Nebulized salbutamol is by beta1stimulation. Selective beta2agonists have a recommended as a primary method of treatment of good bronchodilatory effect with minimal side asthmatic attacks in childhood. effects;' the bronchodilatory effect is even greater if the drug is inhaled into the lungs.2 3 In this study we Arch Dis Child: first published as 10.1136/adc.59.7.666 on 1 July 1984. Downloaded from Adrenaline and nebulized salbutamol in acute asthmla 667 have compared the effects of injected adrenaline l-- and nebulized salbutamol on acute asthma in |Salbutamol group children. Salbutamol has recently been shown in a .10 Adrencdine group| similar study to be as effective as adrenaline.4 Patients and methods Forty six children attending clinic because of acute asthma were entered into the study. The children _50 were randomised into two groups-20 children (6 girls and 14 boys) of age, mean (SD) 11-2 (1-8) years ?L 0 were treated with adrenaline (10 ,ug/kg im) and 26 (11 girls and 15 boys) age mean (SD) 11-4 (2-1) x4' - years were treated with salbutamol (0-15 mg/kg). The adrenaline dose was reduced to 6 sg/kg and the I- salbutamol dose to 0-075 mg/kg if the child had 0 10 20 received sympathomimetic drugs in the 8 hour Time (minutes) period before coming to the clinic. Salbutamol, Figure The effect of treatment ofasthmatic attack with diluted with physiologic saline to 2 ml, was adminis- injected adrenaline or inhaled salbutamol on peak tered by face mask and compressor nebulizer (Spira, expiratory flow rate. Module 2; Hameenlinnan Tyokeskus, Finland) using an airflow rate of 7 litres/minute over 5 to expiratory flow was greater for children treated with 10 minutes. Before the treatment and 10 and 30 salbutamol than for those given adrenaline. The minutes afterwards the following measurements difference was highly significant at 10 minutes were made; peak expiratory flow, respiratory rate, (P<0-001) and significant (P<0-002) at 30 minutes. blood pressure, and heart rate. To obtain reliable Nine patients (45%) in the adrenaline group and peak expiratory flow values only children aged 7 five (19%) in the salbutamol group were admitted to years or more were included in the study. The hospital and among these the mean peak expiratory clinical condition of 14 patients was considered flow values were less than 50% of predicted. In sufficiently serious to require admission to hospital those children allowed to return home the mean after the initial treatment. values were over 50% in both treatment groups http://adc.bmj.com/ (Table). There were no significant changes in Results respiratory rate, blood pressure, and pulse rate in either group. Muscle tremor occurred in five chil- The absolute peak expiratory flow value was con- dren in the adrenaline group and in two children in verted to a percentage of the predicted normal the salbutamol group. value using a nomogram.5 Before treatment there was no significant difference in the mean values Discussion between the groups. Peak expiratory flow rates on September 27, 2021 by guest. Protected copyright. expressed as a percentage of normal predicted The results show that both injected adrenaline and values of treatment and 10 and 30 minutes after- inhaled salbutamol have a good bronchodilatory wards are shown in the Figure; in both groups the effect on acute asthma in children aged 7 years or improvement was highly significant at both 10 and older. Salbutamol was significantly more effective 30 minutes after treatment. The average improve- than adrenaline both at 10 and 30 minutes after ment expressed as a percentage change in peak treatment. The superiority of salbutamol over adre- Table Peak expiratoryflow expressed as a percentage ofthe predicted normal value in asthmatic children adtmitted to hospital and in those allowed to return home Tr-eaueul with/ aild etnaline Tr(ete(d wit/itli salbutatuiol Home Ho.spital Home1(u HIospunitl No I1 9 21 5 At treatment (mean (SD)) 45 (15.1) 28 (13-1) 381- (12*6) 17-2 (5-I) 10 minutes aifter treaitment (meian (SD)) 66-5 (14 6) 39-9 (26-2) 72-4 (1895) 61-8 (13 0) 3(0 minutes after treatment (mean (SD)) 67-2 (16-2) 33 5 (17-0) 76-2 ('04) 46.7 ('l48) Arch Dis Child: first published as 10.1136/adc.59.7.666 on 1 July 1984. Downloaded from 668 Turpeinen, Kuokkanen, and Baclckman naline may also be seen in the number of patients 3 Thiringer G. Svedimlvr N. Comparison of infused and inhalled subsequently needing hospital treatment. The salbu- terbutailine in patients with asthma. Scoadiniavian Joorool oJ Respiratorv D)iseases 1976;57:17-24 tamol doses used in this study seemed to be 4 Beckcr A. Nclson N. Siinons F. Inhailcd salbutarnol vs injectcd safe-there were no cardiovascular side effects and epinephrine in the treatment of acutc asthma in children. muscular tremor occurred in only two out of 26 J Pedi(atr 1983;t102:465-9. children. Inhaled salbutamol seems to be the treat- Wcng TR. Lcvison 11. Standards of pulmonary functionl in ment of choice in childhood asthmatic attacks. childrcin. Atn Ret' Respir Dis 1969:99:879. References Corrcspondcncc to Dr Markku Turpcincn. Allcrgy Hospital. Univcrsity Ccntrail Hospital of Hclsinki. Mcilalhdncrtitc 2. 0)025 Norn S.
Recommended publications
  • FSI-D-16-00226R1 Title
    Elsevier Editorial System(tm) for Forensic Science International Manuscript Draft Manuscript Number: FSI-D-16-00226R1 Title: An overview of Emerging and New Psychoactive Substances in the United Kingdom Article Type: Review Article Keywords: New Psychoactive Substances Psychostimulants Lefetamine Hallucinogens LSD Derivatives Benzodiazepines Corresponding Author: Prof. Simon Gibbons, Corresponding Author's Institution: UCL School of Pharmacy First Author: Simon Gibbons Order of Authors: Simon Gibbons; Shruti Beharry Abstract: The purpose of this review is to identify emerging or new psychoactive substances (NPS) by undertaking an online survey of the UK NPS market and to gather any data from online drug fora and published literature. Drugs from four main classes of NPS were identified: psychostimulants, dissociative anaesthetics, hallucinogens (phenylalkylamine-based and lysergamide-based materials) and finally benzodiazepines. For inclusion in the review the 'user reviews' on drugs fora were selected based on whether or not the particular NPS of interest was used alone or in combination. NPS that were use alone were considered. Each of the classes contained drugs that are modelled on existing illegal materials and are now covered by the UK New Psychoactive Substances Bill in 2016. Suggested Reviewers: Title Page (with authors and addresses) An overview of Emerging and New Psychoactive Substances in the United Kingdom Shruti Beharry and Simon Gibbons1 Research Department of Pharmaceutical and Biological Chemistry UCL School of Pharmacy
    [Show full text]
  • Octopamine and Tyramine Regulate the Activity of Reproductive Visceral Muscles in the Adult Female Blood-Feeding Bug, Rhodnius Prolixus Sam Hana* and Angela B
    © 2017. Published by The Company of Biologists Ltd | Journal of Experimental Biology (2017) 220, 1830-1836 doi:10.1242/jeb.156307 RESEARCH ARTICLE Octopamine and tyramine regulate the activity of reproductive visceral muscles in the adult female blood-feeding bug, Rhodnius prolixus Sam Hana* and Angela B. Lange ABSTRACT Monastirioti et al., 1996). Octopamine and tyramine signal via The role of octopamine and tyramine in regulating spontaneous G-protein coupled receptors (GPCRs), leading to changes in second contractions of reproductive tissues was examined in the messenger levels. The recently updated receptor classification α β female Rhodnius prolixus. Octopamine decreased the amplitude of (Farooqui, 2012) divides the receptors into Oct -R, Oct -Rs β β β spontaneous contractions of the oviducts and reduced RhoprFIRFa- (Oct 1-R, Oct 2-R, Oct 3-R), TYR1-R and TYR2-R. In general, β α induced contractions in a dose-dependent manner, whereas tyramine Oct -Rs lead to elevation of cAMP while Oct -R and TYR-Rs lead to 2+ only reduced the RhoprFIRFa-induced contractions. Both octopamine an increase in Ca (Farooqui, 2012). and tyramine decreased the frequency of spontaneous bursal The movement of eggs in the reproductive system of contractions and completely abolished the contractions at Rhodnius prolixus starts at the ovaries, the site of egg maturation. 5×10−7 mol l−1 and above. Phentolamine, an octopamine receptor Upon ovulation, mature eggs are released into the oviducts antagonist, attenuated the inhibition induced by octopamine on the (Wigglesworth, 1942). Eggs are then guided, via oviductal oviducts and the bursa. Octopamine also increased the levels of peristaltic and phasic contractions, to the common oviduct, where cAMP in the oviducts, and this effect was blocked by phentolamine.
    [Show full text]
  • Summary of Product Characteristics
    Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Salbutamol CFC-Free Inhaler 100 micrograms per metered dose, pressurised inhalation, suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One metered dose contains 100 micrograms of salbutamol (equivalent to 120 micrograms of salbutamol sulphate). This is equivalent to a delivered dose of 90 micrograms of salbutamol (equivalent to 108 micrograms of salbutamol sulphate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pressurised inhalation suspension Pressurised inhalation suspension supplied in an aluminium canister with a metering valve and a plastic actuator and dust cap. 4 CLINICAL PARTICULARS 4.1 Therapeutic Indications Salbutamol CFC-Free Inhaler is indicated in adults, adolescents and children. For babies and children under 4 years of age, see sections 4.2 and 5.1. Salbutamol CFC-Free Inhaler is indicated for the relief and prevention of bronchial asthma and conditions associated with reversible airways obstruction. Salbutamol CFC-Free Inhaler can be used as relief medication in the management of mild, moderate or severe asthma, provided that its use does not delay the introduction and use of regular inhaled corticosteroid therapy, where necessary. 4.2 Posology and method of administration Salbutamol CFC-Free Inhaler is for oral inhalation use only. Posology Adults (including the elderly) and adolescents (children 12 years and over): For the relief of acute bronchospasm, one inhalation (100 micrograms) increasing to two inhalations (200 micrograms), if necessary. To prevent allergen- or exercise-induced symptoms, two inhalations (200 micrograms) should be taken 10-15 minutes before challenge. Maximum daily dose: two inhalations (200 micrograms) up to four times a day.
    [Show full text]
  • Can Hepatic Coma Be Caused by a Reduction of Brain Noradrenaline Or Dopamine?
    Gut: first published as 10.1136/gut.18.9.688 on 1 September 1977. Downloaded from Gut, 1977, 18, 688-691 Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? L. ZIEVE AND R. L. OLSEN From the Department ofMedicine, Minneapolis Veterans Hospital, University of Minnesota, Minneapolis, and Department of Chemistry, Hamline University, St. Paul, Minnesota, USA SUMMARY Intraventricular infusions of octopamine which raised brain octopamine concentrations more than 20 000-fold resulted in reductions in brain noradrenaline and dopamine by as much as 90% without affecting the alertness or activity of normal rats. As this reduction of brain catechol- amines is much greater than any reported in hepatic coma, we do not believe that values observed in experimental hepatic failure have aetiological significance for the encephalopathy that ensues. Though catecholaminergic nerve terminals represent dopamine and noradrenaline had no discernible only a small proportion of brain synapses (Snyder et effect on the state of alertness of the animals. al., 1973), the reduction in brain dopamine or nor- adrenaline by the accumulation of false neuro- Methods transmitterssuch as octopamine or of aromaticamino acids such as phenylalanine or tyrosine has been ANIMALS suggested as a cause of hepatic coma (Fischer and Male Sprague-Dawley rats weighing between 300 and Baldessarini, 1971; Dodsworth et al., 1974; Fischer 350 were g prepared by the method of Peterson and http://gut.bmj.com/ and Baldessarini, 1975; Munro et al., 1975). The Sparber (1974) for intraventricular infusions of following data have been cited in support of this octopamine. Rats of 250-400 g were used as controls.
    [Show full text]
  • Supporting Information a Analysed Substances
    Electronic Supplementary Material (ESI) for Analyst. This journal is © The Royal Society of Chemistry 2020 List of contents: Tab. A1 Detailed list and classification of analysed substances. Tab. A2 List of selected MS/MS parameters for the analytes. Tab. A1 Detailed list and classification of analysed substances. drug of therapeutic doping agent analytical standard substance abuse drug (WADA class)* supplier (+\-)-amphetamine ✓ ✓ S6 stimulants LGC (+\-)-methamphetamine ✓ S6 stimulants LGC (+\-)-3,4-methylenedioxymethamphetamine (MDMA) ✓ S6 stimulants LGC methylhexanamine (4-methylhexan-2-amine, DMAA) S6 stimulants Sigma cocaine ✓ ✓ S6 stimulants LGC methylphenidate ✓ ✓ S6 stimulants LGC nikethamide (N,N-diethylnicotinamide) ✓ S6 stimulants Aldrich strychnine S6 stimulants Sigma (-)-Δ9-tetrahydrocannabinol (THC) ✓ ✓ S8 cannabinoids LGC (-)-11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) S8 cannabinoids LGC morphine ✓ ✓ S7 narcotics LGC heroin (diacetylmorphine) ✓ ✓ S7 narcotics LGC hydrocodone ✓ ✓ Cerillant® oxycodone ✓ ✓ S7 narcotics LGC (+\-)-methadone ✓ ✓ S7 narcotics Cerillant® buprenorphine ✓ ✓ S7 narcotics Cerillant® fentanyl ✓ ✓ S7 narcotics LGC ketamine ✓ ✓ LGC phencyclidine (PCP) ✓ S0 non-approved substances LGC lysergic acid diethylamide (LSD) ✓ S0 non-approved substances LGC psilocybin ✓ S0 non-approved substances Cerillant® alprazolam ✓ ✓ LGC clonazepam ✓ ✓ Cerillant® flunitrazepam ✓ ✓ LGC zolpidem ✓ ✓ LGC VETRANAL™ boldenone (Δ1-testosterone / 1-dehydrotestosterone) ✓ S1 anabolic agents (Sigma-Aldrich)
    [Show full text]
  • Structure-Cytotoxicity Relationship Profile of 13 Synthetic Cathinones In
    Neurotoxicology 75 (2019) 158–173 Contents lists available at ScienceDirect Neurotoxicology journal homepage: www.elsevier.com/locate/neuro Structure-cytotoxicity relationship profile of 13 synthetic cathinones in differentiated human SH-SY5Y neuronal cells T ⁎ Jorge Soaresa, , Vera Marisa Costaa, Helena Gasparb,c, Susana Santosd,e, Maria de Lourdes Bastosa, ⁎ Félix Carvalhoa, João Paulo Capelaa,f, a UCIBIO, REQUIMTE (Rede de Química e Tecnologia), Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Portugal b BioISI – Instituto de Biossistemas e Ciências Integrativas, Faculdade de Ciências, Universidade de Lisboa, Portugal c MARE - Centro de Ciências do Mar e do Ambiente, Escola Superior de Turismo e Tecnologia do Mar, Instituto Politécnico de Leiria, Portugal d Centro de Química e Bioquímica (CQB), Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Portugal e Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Portugal f FP-ENAS (Unidade de Investigação UFP em Energia, Ambiente e Saúde), CEBIMED (Centro de Estudos em Biomedicina), Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Portugal ARTICLE INFO ABSTRACT Keywords: Synthetic cathinones also known as β-keto amphetamines are a new group of recreational designer drugs. We Synthetic cathinones aimed to evaluate the cytotoxic potential of thirteen cathinones lacking the methylenedioxy ring and establish a Classical amphetamines putative structure-toxicity profile using differentiated SH-SY5Y cells, as well as to compare their toxicity to that Cytotoxicity of amphetamine (AMPH) and methamphetamine (METH). Cytotoxicity assays [mitochondrial 3-(4,5-dimethyl-2- SH-SY5Y cells thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction and lysosomal neutral red (NR) uptake] per- Structure-toxicity relationship formed after a 24-h or a 48-h exposure revealed for all tested drugs a concentration-dependent toxicity.
    [Show full text]
  • Prodrugs Design Based on Inter- and Intramolecular Chemical Processes
    Chem Biol Drug Des 2013; 82: 643–668 Review Prodrugs Design Based on Inter- and Intramolecular Chemical Processes Rafik Karaman1,2,* compound satisfies a number of preset criteria to start clinical development. The number of years it takes to intro- 1Bioorganic Chemistry Department, Faculty of Pharmacy, duce a drug to the pharmaceutical market is over 10 years Al-Quds University, P.O. Box 20002, Jerusalem, Palestine with a cost of more than $1 billion dollars (1,2). 2Department of Science, University of Basilicata, Via dell’Ateneo Lucano 10, 85100, Potenza, Italy Modifying the absorption, distribution, metabolism, and *Corresponding author: Rafik Karaman, elimination (ADME) properties of an active drug requires a [email protected] complete understanding of the physicochemical and bio- logical behavior of the drug candidate (3 6). This includes This review provides the reader a concise overview of – the majority of prodrug approaches with the emphasis comprehensive evaluation of drug-likeness involving on the modern approaches to prodrug design. The prediction of ADME properties. These predictions can be chemical approach catalyzed by metabolic enzymes attempted at several levels: in vitro–in vivo using data which is considered as widely used among all other obtained from tissue or recombinant material from human approaches to minimize the undesirable drug physico- and preclinical species, and in silico or computational pre- chemical properties is discussed. Part of this review dictions projecting in vitro or in vivo data, involving the will shed light on the use of molecular orbital methods evaluation of various ADME properties, using computa- such as DFT, semiempirical and ab initio for the design tional approaches such as quantitative structure activity of novel prodrugs.
    [Show full text]
  • The 2013 "Research on Drug Evidence"
    The 2013 “Research on Drug Evidence” Report [From the 17th ICPO / INTERPOL Forensic Science Symposium] Robert F. X. Klein U.S. Department of Justice Drug Enforcement Administration Special Testing and Research Laboratory 22624 Dulles Summit Court Dulles, VA 20166 [[email protected]] ABSTRACT: A reprint of the 2013 “Research on Drug Evidence” Report (a review) is provided. KEYWORDS: INTERPOL, Illicit Drugs, Controlled Substances, Forensic Chemistry. Important Information: Distributed at the 17th ICPO / INTERPOL Forensic Science Symposium, Lyon, France, October 8 - 10, 2013.* Authorized Reprint. Copyright INTERPOL. All rights reserved. May not be reprinted without express permission from INTERPOL. For pertinent background, see: Klein RFX. ICPO / INTERPOL Forensic Science Symposia, 1995 - 2016. “Research on Drug Evidence”. Prefacing Remarks (and a Request for Information). Microgram Journal 2016;13(1-4):1-3. Citations in this report from the Journal of the Clandestine Laboratory Investigating Chemists Association were (and remain) Law Enforcement Restricted. The "General Overview" (Talking Paper) was removed from this reprint (Editor's discretion). This reprint is derived from the original electronic document, and is not an image of the best available hard copy (as was utilized for the 1995 and 1998 reports). For this reason, the pagination in the Proceedings is not retained in this reprint, some minor reformatting was done to eliminate deadspace, and all widow and orphan lines were left as is. [* Due to travel restrictions in effect in late 2013, this report and the associated "General Overview" (Talking Paper) was not actually presented, but rather the report was only distributed to the attendees.] Microgram Journal 2016, Volume 13; Numbers 1-4 511 Research on Drug Evidence January 1, 2010 - June 30, 2013 Presented by: Jeffrey H.
    [Show full text]
  • Annex 2B Tariff Schedule of the United States See General Notes to Annex 2B for Staging Explanation HTSUS No
    Annex 2B Tariff Schedule of the United States See General Notes to Annex 2B for Staging Explanation HTSUS No. Description Base Rate Staging 0101 Live horses, asses, mules and hinnies: 0101.10.00 -Purebred breeding animals Free E 0101.90 -Other: 0101.90.10 --Horses Free E 0101.90.20 --Asses 6.8% B --Mules and hinnies: 0101.90.30 ---Imported for immediate slaughter Free E 0101.90.40 ---Other 4.5% A 0102 Live bovine animals: 0102.10.00 -Purebred breeding animals Free E 0102.90 -Other: 0102.90.20 --Cows imported specially for dairy purposes Free E 0102.90.40 --Other 1 cent/kg A 0103 Live swine: 0103.10.00 -Purebred breeding animals Free E -Other: 0103.91.00 --Weighing less than 50 kg each Free E 0103.92.00 --Weighing 50 kg or more each Free E 0104 Live sheep and goats: 0104.10.00 -Sheep Free E 0104.20.00 -Goats 68 cents/head A 0105 Live poultry of the following kinds: Chickens, ducks, geese, turkeys and guineas: -Weighing not more than 185 g: 0105.11.00 --Chickens 0.9 cents each A 0105.12.00 --Turkeys 0.9 cents each A 0105.19.00 --Other 0.9 cents each A -Other: 0105.92.00 --Chickens, weighing not more than 2,000 g 2 cents/kg A 0105.93.00 --Chickens, weighing more than 2,000 g 2 cents/kg A 0105.99.00 --Other 2 cents/kg A 0106 Other live animals: -Mammals: 0106.11.00 --Primates Free E 0106.12.00 --Whales, dolphins and porpoises (mammals of the order Cetacea); manatees and dugongs (mammals of the order Sirenia) Free E 0106.19 --Other: 2B-Schedule-1 HTSUS No.
    [Show full text]
  • Orciprenaline Sulphate (Alupent): Planned Withdrawal from the UK Market Following a Risk-Benefit Analysis
    MHRA PUBLIC ASSESSMENT REPORT Orciprenaline sulphate (Alupent): planned withdrawal from the UK market following a risk-benefit analysis November 2009 Executive summary 2 1. Introduction 3 2. Summary of data 3 2.1 Clinical pharmacology 3 2.2 Efficacy 3 2.3 Safety 4 3. Conclusions 8 4. References 9 5. Glossary 10 1 EXECUTIVE SUMMARY (Please note that this summary is intended to be accessible to all members of the public, including health professionals) Background The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency responsible for regulating the effectiveness and safety of medicines and medical devices in the UK. We continually review the safety of all medicines in the UK, and inform healthcare professionals and the public of the latest safety updates. In our Public Assessment Reports, we discuss the evidence for a safety issue with a particular drug or drug class, and changes made to the product information for the drug on the basis of this evidence, which will help safeguard public health. This MHRA Public Assessment Report discusses a review of the risks and benefits of a medicine called orciprenaline sulphate. Orciprenaline sulphate is available for oral administration as a syrup used to treat reversible airways obstructiona, which is a symptom of asthmab and chronic obstructive pulmonary diseasec. It acts on specific areas in the body called β- receptors, which relaxes the muscles used for breathing and opens the airways in the lungs. Orciprenaline sulphate was licensed in 1972 and is marketed in the UK under the brand name Alupent Syrup. As with any medicine, the use of orciprenaline sulphate may lead to adverse reactions (side-effects) in some individuals, which are described in the product information, including the patient information leaflet (see the Electronic Medicines Compendium (product information) website).
    [Show full text]
  • Methedrine, Neo-Synephrine, Paredrine, and Pholedrine
    Br Heart J: first published as 10.1136/hrt.6.4.214 on 1 October 1944. Downloaded from CLINICAL EVALUATION OF THE PRESSOR ACTIVITY OF METHEDRINE, NEO-SYNEPHRINE, PAREDRINE, AND PHOLEDRINE BY FREDERICK PRESCOTT From the Wellcome Research Institution, London Received October 10, 1944 Recently a number of pressor drugs of the adrenaline type have come into clinical use for the treatment of low blood pressure following surgical procedures, spinal anxsthesia, circu- latory collapse, and surgical and traumatic shock. For therapeutic purposes the ideal pressor drug should be effective by the intramuscular or intravenous route; it should act rapidly; it should produce a sustained elevation of blood pressure, so that frequent injections of the drug are not necessary; and it should have no undesirable effects on the cardiovascular system and no untoward side effects. Adrenaline and ephedrine were the first drugs to be used clinically to raise the blood pressure in cases of operative shock. Their limitations, however, are nowv well known. Adrenaline may do more harm than good beca4se in thera- peutic doses intrayenously it causes a considerable rise of blood pressure, e.g. 200 mm. to 300 mm. of mercury, with a precipitous fall after a few minutes to a level lower than before. Similarly ephedrine, which for dependable results must be given intravenously, produces a http://heart.bmj.com/ sharp rise of blood pressure that lasts only for ten to twenty minutes. Other pressor drugs have been introduced with a more sustained action. In most of the studies reported on these, however, no definite criteria seem to have been employed in their evaluation, nor have the conditions of administration been standardized.
    [Show full text]
  • The Organic Chemistry of Drug Synthesis
    The Organic Chemistry of Drug Synthesis VOLUME 2 DANIEL LEDNICER Mead Johnson and Company Evansville, Indiana LESTER A. MITSCHER The University of Kansas School of Pharmacy Department of Medicinal Chemistry Lawrence, Kansas A WILEY-INTERSCIENCE PUBLICATION JOHN WILEY AND SONS, New York • Chichester • Brisbane • Toronto Copyright © 1980 by John Wiley & Sons, Inc. All rights reserved. Published simultaneously in Canada. Reproduction or translation of any part of this work beyond that permitted by Sections 107 or 108 of the 1976 United States Copyright Act without the permission of the copyright owner is unlawful. Requests for permission or further information should be addressed to the Permissions Department, John Wiley & Sons, Inc. Library of Congress Cataloging in Publication Data: Lednicer, Daniel, 1929- The organic chemistry of drug synthesis. "A Wiley-lnterscience publication." 1. Chemistry, Medical and pharmaceutical. 2. Drugs. 3. Chemistry, Organic. I. Mitscher, Lester A., joint author. II. Title. RS421 .L423 615M 91 76-28387 ISBN 0-471-04392-3 Printed in the United States of America 10 987654321 It is our pleasure again to dedicate a book to our helpmeets: Beryle and Betty. "Has it ever occurred to you that medicinal chemists are just like compulsive gamblers: the next compound will be the real winner." R. L. Clark at the 16th National Medicinal Chemistry Symposium, June, 1978. vii Preface The reception accorded "Organic Chemistry of Drug Synthesis11 seems to us to indicate widespread interest in the organic chemistry involved in the search for new pharmaceutical agents. We are only too aware of the fact that the book deals with a limited segment of the field; the earlier volume cannot be considered either comprehensive or completely up to date.
    [Show full text]